Advertisements


Why Celldex Therapeutics Is Getting Crushed

Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study......»»

Category: blogSource: 247wallstApr 16th, 2018

Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2018 Results - Earnings Call Transcript

Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMar 8th, 2019

First Week of August 16th Options Trading For Celldex Therapeutics (CLDX)

Stock Options Channel.....»»

Category: topSource: redinewsJan 8th, 2019

Here"s Why Celldex Therapeutics Sank on Friday

A rotten week for biotech didn't end well for Celldex......»»

Category: topSource: foxnewsDec 21st, 2018

Why Ovid Therapeutics Is Monday’s Big Biotech Loser

Ovid Therapeutics shares were crushed to start the week even though the company announced positive midstage results for its Angelman syndrome study......»»

Category: blogSource: 247wallstAug 6th, 2018

Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics

Which beaten-down biotech stock wins in a head-to-head match-up?.....»»

Category: topSource: foxnewsJun 29th, 2018

Why Summit Therapeutics Was Crushed

Summit Therapeutics is another biopharma company that is paying the price on Wednesday......»»

Category: blogSource: 247wallstJun 27th, 2018

Celldex Therapeutics Salvage Value

Celldex Therapeutics Salvage Value.....»»

Category: topSource: seekingalphaJun 15th, 2018

Celldex Therapeutics (CLDX) Down 9.2% Since Earnings Report: Can It Rebound?

Zacks.....»»

Category: topSource: redinewsJun 11th, 2018

Why Melinta Therapeutics Shares Are Getting Crushed

Melinta Therapeutics saw its shares plunge on Thursday after the firm announced that it had priced a secondary offering......»»

Category: blogSource: 247wallstMay 24th, 2018

What"s in Store for Celldex (CLDX) This Earnings Season?

With no approved product in Celldex Therapeutics' (CLDX) portfolio, investor focus is on i.....»»

Category: personnelSource: nytMay 3rd, 2018

MGIC, Juniper Networks Slide into Wednesday’s 52-Week Low Club

MGIC Investment Group, Celldex Therapeutics, Juniper Networks, and Healthcare Services Group all posted new 52-week lows on Wednesday......»»

Category: blogSource: 247wallstApr 18th, 2018

Celldex"s Phase II Breast Cancer Study Fails, Shares Plunge

Celldex Therapeutics' (CLDX) glembatumumab vedotin fails to meet primary endpoint in phase IIb METRIC study in metastat.....»»

Category: smallbizSource: nytApr 17th, 2018

Celldex, Acacia Plummet into Monday’s 52-Week Low Club

Celldex Therapeutics, Acacia Communications, Apricus Biosciences, and Ctrp.com all posted new 52-week lows Monday......»»

Category: blogSource: 247wallstApr 16th, 2018

Celldex"s stock plummets toward record low after failed drug study

Shares of Celldex Therapeutics Inc. plummeted 40% in premarket trade Monday toward a record low, after the drug.....»»

Category: topSource: marketwatchApr 16th, 2018

Sorrento Therapeutics subsidiary Scilex announces results from SP-102 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 10 min. ago

Natera to partner with AMAL Therapeutics for clinial trial using MRD Test

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 10 min. ago

Translate Bio issued RNA therapeutics platform patent from USPTO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 10 min. ago

Enlivex Therapeutics announces Nasdaq listing

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 10 min. ago

TCR2 Therapeutics selects Cell and Gene Therapy Catapult in the U.K.

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 10 min. ago

Aldeyra"s Eye Inflammation Drug Aces Late-Stage Trial, Stock Rises 60%

Aldeyra Therapeutics Inc (NASDAQ: ALDX) shares are advancing strongly Tuesday following the release of the results of a late-stage study of its drug candidate for allergic conjunctivitis. Latest R.....»»

Category: blogSource: benzinga1 hr. 10 min. ago